IDH1 and neoplasm: The third patient was ctDNA-positive for the R132C mutation and had a recurrent grade II oligodendroglioma progressing after radiotherapy, where the primary tumor biopsy from 7 years earlier (the last surgery that had been performed) harbored two IDH1 mutations (R132H and R132C).